Armistice Capital, LLC 13D and 13G filings for Kairos Pharma, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 3:19 pm Purchase |
2025-03-31 | 13G | Kairos Pharma, Ltd. KAPA |
Armistice Capital, LLC | 1,696,924 9.990% |
1,696,924 (New Position) |
Filing |